Kenneth Miller, Ph.D. has 18 years of CMC analytical experience in the biopharmaceutical industry. Dr. Miller is currently a leader in the Quality Control Analytical Technologies (QCAT) organization at BioMarin Pharmaceutical and is responsible for Global Stability and CMC Analytical Data Management for clinical and commercial programs within BioMarin’s portfolio. He is also an adjunct faculty member at the University of Maryland, Baltimore County, where he is lead instructor for “Quality Control and Quality Assurance of Biotechnology Products” and serves as a guest lecturer for “Development and Regulation of Biopharmaceuticals”. Prior to joining BioMarin Pharmaceutical, Dr. Miller served in leadership positions with MedImmune Biopharmaceutical Development and AstraZeneca Biologics Global Technical Operations. He received his B.S. in Biochemistry from Case Western Reserve University and Ph.D. in Biological Sciences from Carnegie Mellon University.